Sort   by:  
 Page size 
UnknownDevelopment and comparative evaluation of SARS-CoV-2 S-RBD and N based ELISA tests in various African endemic settings.
Not available
S-EPMC9867841 | biostudies-literature
UnknownKinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: A prospective longitudinal study.
Not available
S-EPMC10337929 | biostudies-literature
UnknownPhase I study of afatinib combined with nintedanib in patients with advanced solid tumours.
Not available
S-EPMC4815889 | biostudies-literature
UnknownPooled safety analysis of two phase 3 studies investigating trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer.
Not available
S-EPMC11779617 | biostudies-literature
UnknownFirst-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study.
Not available
S-EPMC9130487 | biostudies-literature
UnknownEffect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysis.
Not available
S-EPMC9271514 | biostudies-literature
UnknownTrifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study.
Not available
S-EPMC8453191 | biostudies-literature
UnknownHealth-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS.
Not available
S-EPMC7305098 | biostudies-literature
Sort   by:  
 Page size